MRK

Merck News - MRK

Buy
Sell
Best deals to access real time data!
USA CHART Trader
Monthly Subscription
for only
US$30.66
Real-time Level 1 for Canada + USA
Monthly Subscription
for only
US$38.05
USA Small Cap Basic
Monthly Subscription
for only
US$33.03
VAT not included
Stock Name Stock Symbol Market Stock Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Price Change % Stock Price Last Trade
-0.66 -0.89% 73.23 12:00:01
Open Price Low Price High Price Close Price Previous Close
74.31 72.66 74.31 73.34 73.89
more quote information »

Recent News

Date Time Source Heading
04/12/202110:15BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant..
04/12/202108:55SEEKMerck's Keytruda approved as adjuvant therapy for stage IIb,..
04/12/202107:00DJNMerck in Supply Agreement With Canada for Antiviral Medicine..
04/12/202106:10PRNCAMerck Canada annonce la conclusion d'un accord..
04/12/202106:08PRNCAMerck Canada Announces Supply Agreement of Up to 1 Million..
03/12/202123:46DJNBristol Myers Squibb Gets FDA Acceptance of sBLA for..
03/12/202118:16DJNMerck Applies for Covid Pill Approval in Japan, Nikkei..
02/12/202101:29SEEKMerck draws mixed views on Street despite backing from FDA..
01/12/202123:36DJNMerck Gets FDA Priority Review of Vaxneuvance Vaccine in..
01/12/202123:08SEEKFDA accepts for priority review Merck's Vaxneuvance..
01/12/202122:45BWU.S. FDA Accepts for Priority Review the Supplemental..
01/12/202121:59TRMNFDA Committee Votes in Favor of Merck’s COVID-19 Pill
01/12/202109:51BWMerck and Ridgeback Statement on Positive FDA Advisory..
01/12/202109:13SEEKFDA advisors recommend authorization of Merck COVID..
01/12/202107:03SEEKMerck raises dividend by ~6% to $0.69
01/12/202106:48BWMerck Announces First-Quarter 2022 Dividend
01/12/202104:07SEEKMerck expects COVID-19 pill to be effective against any..
30/11/202123:12SEEKMerck’s Keytruda + chemotherapy OK'd in Japan for esophageal..
30/11/202123:00DJNAstraZeneca: Lynparza Gets FDA Priority Review -- Update
30/11/202122:45BWMerck’s KEYTRUDA® (pembrolizumab) Approved in Japan in..
30/11/202122:30BWFDA Accepts Regulatory Submission of Supplemental New Drug..
30/11/202105:48SEEKWhile Merck's COVID pill molnupiravir is poised for..
30/11/202103:06SEEKMerck dips further to reach a two-month low amid Citi..
29/11/202123:56SEEKEuropean Commission approves Merck's Keytruda + Lenvima for..
29/11/202123:28DJNMerck, Eisai Get Europe OK for Lenvima/Keytruda Combination..
29/11/202122:50BWEuropean Commission Approves KEYTRUDA® (pembrolizumab) Plus..
29/11/202122:45BWEuropean Commission Approves KEYTRUDA® (pembrolizumab) Plus..
27/11/202100:35TRMNMerck & Company (MRK) Gets a Buy Rating from Mizuho..
26/11/202123:48SEEKMerck stock down 3% after its COVID-19 pill shows lower..
26/11/202122:45BWMerck and Ridgeback Biotherapeutics Provide Update on..
25/11/202103:50TRMNBerenberg Bank Keeps a Hold Rating on Merck & Company (MRK)
24/11/202122:45BWMerck to Present at the 4th Annual Evercore ISI HealthCONx..
24/11/202110:25TRMNMizuho Securities Sticks to Their Buy Rating for Merck &..
24/11/202109:31SEEKGilead, Merck pause enrollment in phase 2 HIV combination..
24/11/202104:16SEEKEMA begins review of Merck's COVID pill molnupiravir;..
24/11/202103:55DJNHealth Canada Approves Keytruda in Combination to Treat..
24/11/202103:48SEEKMerck secures Health Canada approval for Keytruda and chemo..
24/11/202103:02PRNCASanté Canada approuve KEYTRUDA® (pembrolizumab), en..
24/11/202103:01PRNCAHealth Canada Approves KEYTRUDA® (pembrolizumab) in..
22/11/202123:43SEEKMerck announces completion of Acceleron Pharma acquisition
22/11/202122:45BWMerck Completes Acquisition of Acceleron Pharma Inc.
20/11/202110:06BWMerck Completes Tender Offer to Acquire Acceleron Pharma..
20/11/202105:06SEEKEMA recommends Merck's COVID antiviral molnupiravir for..
20/11/202103:46DJNEU Says Merck's Covid-19 Pill Can Be Used in Some Cases, Is..
19/11/202123:13SEEKMerck halts development of HIV drug after decreases in white..
19/11/202109:57BWMerck Provides Update on Phase 2 Clinical Trial of..
18/11/202123:48DJNMerck Gets FDA Expanded Keytruda OK in Some Kidney Cancer..
18/11/202123:03SEEKMerck granted FDA approval for Keytruda as adjuvant therapy..
18/11/202122:45BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant..
17/11/202122:45BWMerck Announces Expiration of Hart-Scott-Rodino Act Waiting..
See more news about this stock »
Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211204 18:58:59